Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Indoco Remedies Limited ( (IN:INDOCO) ) has shared an update.
Indoco Remedies Limited has announced a substantial acquisition of shares by its promoters, Aditi Milind Panandikar and Aruna Suresh Kare, through the Kare Family Private Trust (KFPT). This acquisition involves both direct and indirect purchases, including significant stakes in the promoter company Shanteri Investment Private Limited (SIPL), which will enhance KFPT’s influence in Indoco Remedies. This move is likely to strengthen the promoters’ control over the company and could have implications for its strategic direction and shareholder dynamics.
More about Indoco Remedies Limited
Indoco Remedies Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of pharmaceutical formulations. The company is known for its wide range of therapeutic products and has a significant presence in both domestic and international markets.
Average Trading Volume: 20,327
Technical Sentiment Signal: Sell
Current Market Cap: 24.16B INR
See more data about INDOCO stock on TipRanks’ Stock Analysis page.